Compare POM & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POM | MYO |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.8M | 39.2M |
| IPO Year | 2025 | 2017 |
| Metric | POM | MYO |
|---|---|---|
| Price | $0.30 | $0.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | ★ 1.3M | 618.0K |
| Earning Date | 12-03-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $51,210,721.00 | $41,643,203.00 |
| Revenue This Year | N/A | $24.07 |
| Revenue Next Year | N/A | $17.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 12.13 | ★ 65.00 |
| 52 Week Low | $0.26 | $0.71 |
| 52 Week High | $6.43 | $6.45 |
| Indicator | POM | MYO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 45.58 |
| Support Level | N/A | $0.96 |
| Resistance Level | N/A | $1.05 |
| Average True Range (ATR) | 0.00 | 0.07 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 6.95 |
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).